Oral contraceptives (OCs) are used by many millions of healthy young women. Their ease of
use and efficacy against unwanted pregnancy has made them an indispensable part of …

The results of three independent studies of venous thromboembolic disease (VTE) and oral
contraceptives are reviewed together with two further cohort/case-control studies which we …

Background and purpose of the workshop Concern about the venous thromboembolism
(VTE) risk of new hormonal contraceptive options shortly after their entry into the market has …

Additional evidence has since shown that the progestins used in combination oral
contraceptives can also affect the risk of thrombosis. 11 Recent studies have shown a 2-to 6 …

Combined oral contraceptives (COCs) induce several changes in the levels of coagulation
factors. The levels of procoagulant factors are often increased, while levels of anticoagulant …

The results of three independent studies of venous thromboembolic disease (VTE) and oral
contraceptives are reviewed together with two further cohort/case-control studies which we …

Objective. The scientific debate on oral contraceptives (OCs) and thrombotic diseases
continues unabated. The aim of this survey was to evaluate available scientific data on OCs …

The objective of this study was to assess the influence of oral contraceptives (OCs) on the
risk of venous thromboembolism (VTE) in young women. A 5-year case-control study …

The risks of venous thromoembolism, myocardial infarction and ischaemic stroke are
increased in oral contraceptive users, even with oral contraceptives with≤ 35 μg of …

Oral contraceptives (OC) are either composed of a combination of an estrogen derivative
(usually ethinly estradiol) and a progestogen, or they contain a progestogen only. OC are …